Journal Article

Diagnostic accuracy of Truenat Tuberculosis and Rifampicin-Resistance assays in Addis Ababa, Ethiopia

Meaza, Abyot, Diriba, Getu, Mohamed, Zemedu, Eshetu, Kirubel, Getu, Melak, Zerihun, Betselot, Yenew, Bazezew, Mollalign, Hilina, Moga, Shewki, Tadesse, Mengistu, Tesfaye, Ephrem, Getahun, Muluwork, Alemu, Ayinalem, Gumi, Balako, Tola, Habteyes Hailu, Kebede, Abebaw, Amare, Miskir, Sinshaw, Waganeh, Seid, Getachew, Dagne, Biniyam, Abebaw, Yeshiwork, Fikadu, Dinka

2021

Overview

Rapid and sensitive Tuberculosis (TB) diagnosis closer to patients is a key global TB control priority. Truenat assays (MTB, MTB Plus, and MTB-RIF Dx) are new TB molecular diagnostic tools for the detection of TB and Rifampicin (RIF)-resistance from sputum samples. The diagnostic accuracy of the assays is needed prior to implementation in clinical use in Ethiopia. This study aimed to determine the sensitivity and specificity of Truenat assays; and aimed to compare the assays to the Xpert MTB/RIF assay. A prospective evaluation study was conducted among 200 presumptive TB patients in microscopy centers in Addis Ababa, Ethiopia from May 2019 to December 2020. Culture (Solid and Liquid methods) and phenotypic (liquid method) drug susceptibility testing (DST) were used as a reference standard. Of 200 adult participants, culture confirmed TB cases were 25 (12.5%), and only one isolate was resistant to RIF by phenotypic DST. The sensitivity of Truenat MTB was 88.0% [95% CI 70.1, 95.8], while 91.7 [95% CI 74.2, 97.7] for Truenat MTB Plus at the microscopy centers. The specificity of Truenat MTB was 97.2% [95% CI 93.1, 98.9], while for Truenat MTB Plus was 97.2% [95% CI 93.0, 99.0]. The sensitivity of Truenat MTB was 90.5% while for MTB Plus, 100% compared to the Xpert MTB/RIF assay. Truenat assays were found to have high diagnostic accuracy. The assays have the potential to be used as a point of care (POC) TB diagnostic tests.

• Publisher: Public Library of Science,Public Library of Science (PLoS)
• Subject: Accuracy / Adolescent / Adult / Aged / Aged, 80 and over / Assaying / Biological Assay / Biology and Life Sciences / Care and treatment / Complications and side effects / Consent / Deoxyribonucleic acid / Diagnosis / Diagnostic Tests, Routine - standards / DNA / Ethiopia / Female / Humans / Laboratories / Male / Medical diagnosis / Medicine and Health Sciences / Microscopy / Middle Aged / Patient outcomes / Patients / People and Places / Physical Sciences / Public health / Research and analysis methods / Rifampin / Rifampin - therapeutic use / Sensitivity / Sputum / Sputum - microbiology / Tuberculosis / Tuberculosis, Multidrug-Resistant - diagnosis / Tuberculosis, Multidrug-Resistant - drug therapy / Young Adult